carvedilol has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, DP | 1 |
| Short, BG | 1 |
| Cyronak, MJ | 1 |
| Contino, LC | 1 |
| DiCristo, M | 1 |
| Wang, YX | 1 |
| Ruffolo, RR | 1 |
| Van den Branden, C | 1 |
| Gabriels, M | 1 |
| Vamecq, J | 1 |
| Vanden Houte, K | 1 |
| Verbeelen, D | 1 |
2 other studies available for carvedilol and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Urea Nitrogen; Captopril; Carbazoles; Ca | 1993 |
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
Topics: Adrenergic beta-Antagonists; Aldehydes; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilo | 1997 |